ArticleAsian Pacific journal of cancer prevention : APJCP2025
Atractylodes lancea Crude Extract Suppresses Triple-Negative Breast Cancer Metastasis via NF-kB signaling Pathway Inhibition.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A systematic review on the application, phytochemistry and pharmacological activities of the genus Atractylodes.Chinese medicine · 2026Review
- Insights into Hepatic, Neuronal, and hERG Channel Safety of Plant-Derived Active Compounds.Journal of xenobiotics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTriple-negative breast cancer (TNBC) is an aggressive subtype characterized by poor prognosis, high recurrence rates, and limited targeted therapies, often leading to metastasis in the brain, bones, lungs, and liver. The NF-kB signaling pathway plays a crucial role in TNBC metastasis. However, the potential of novel herbal medicines as anti-metastatic agents remains underexplored. This study investigates the effects of Atractylodes lancea (AL) crude extract on phosphorylated p65 NF-kB reduction and its impact on TNBC cell migration and invasion.
methodsHigh performance liquid chromatography (HPLC) analysis identified bioactive compounds in AL crude extract. Cytotoxicity was evaluated using MTT assays on MDA-MB-231 cells at 24 and 48 hours. Sub-lethal doses from cytotoxicity assays were used to assess anti-migration and anti-invasive effects via wound healing and gelatin zymography assays, respectively. Immunoblot analysis examined epithelial-mesenchymal transition (EMT)-related proteins and NF-kB expression.
resultAL crude extract significantly inhibited TNBC cell proliferation in a dose- and time-dependent manner, with IC50 values of 92.11±0.01 μg/ml (24 h) and 95.80±0.01 µg/ml (48 h). Wound healing assays confirmed reduced cell migration, while gelatin zymography showed decreased matrix metalloproteinase-9 (MMP-9) enzymatic activity. Immunoblot analysis revealed increased E-cadherin expression, reduced vimentin expression, and significant suppression of phosphorylated NF-κBp65 levels.
conclusionAL crude extract exhibits promising anti-cancer effects by modulating EMT markers, reducing cell motility, and inhibiting NF-κB signaling. These findings suggest its potential as a therapeutic agent for TNBC metastasis suppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.